Oramed Pharmaceuticals Inc. (ORMP)

CIK 1176309 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oramed Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001493152-26-038125
Aug 10, 202610-Q0001213900-26-087361
Aug 3, 2026ARS0001213900-26-084613
Aug 3, 2026DEFA14A0001213900-26-084612
Aug 3, 2026DEF 14A0001213900-26-084609
Jul 22, 2026SCHEDULE 13D/A0001213900-26-080406
Jul 2, 202640001213900-26-075070
Jul 2, 202640001213900-26-075069
Jul 1, 20261440001976408-26-000609
Jul 1, 20261440001976408-26-000608
Jun 30, 20268-K0001213900-26-073709
Jun 29, 2026SCHEDULE 13G/A0001373604-26-000047
Jun 17, 2026SCHEDULE 13D/A0001213900-26-069783
May 19, 202610-Q0001213900-26-059112
May 15, 2026SCHEDULE 13G0001493152-26-023496
May 15, 2026NT 10-Q0001213900-26-057722
May 14, 2026SCHEDULE 13D0001213900-26-056837
May 14, 202630001213900-26-056839
Mar 31, 202640001213900-26-037447
Mar 31, 20268-K0001213900-26-037474
Mar 31, 202640001213900-26-037446
Mar 26, 202610-K0001213900-26-034835
Mar 18, 202640001213900-26-031013
Mar 18, 202640001213900-26-031015
Mar 18, 202640001213900-26-031011